Why Compounded Medications Aren’t FDA Approved (And What That Actually Means)

If you have ever looked into a compounded medication, you have probably seen this statement:

“Compounded medications are not FDA approved.”

And if you do not know what that means, it can sound pretty concerning. Does that mean compounded medications are illegal? No. Does it mean compounding is some sort of loophole outside the healthcare system? No.

Does it mean a compounded medication went through the exact same FDA approval process as a commercially manufactured prescription drug? Also no. The truth is more straightforward:

Compounded medications exist within a different regulatory framework because they are prepared to meet specific patient or healthcare needs rather than being mass-manufactured and submitted to the FDA as a new commercial drug product.

The FDA itself recognizes that compounded medications can serve an important medical need for patients whose needs cannot be met by an FDA-approved medication. Understanding that distinction can make the phrase “not FDA approved” a lot less confusing.

First: What Is a Compounded Medication?

Compounding is the process of preparing a medication for a particular medical need by combining, mixing, or altering ingredients. Unlike a mass-manufactured prescription that arrives at the pharmacy in a standardized commercial package, a compounded prescription may be prepared to meet a patient's specific needs.

For example, the FDA explains that compounding may be appropriate when a patient:

• Is allergic to a dye or other ingredient in an available commercial medication
• Cannot swallow a commercially available tablet or capsule and needs a liquid form
• Needs a medication that is not medically appropriate for them in its commercially available form
• Needs access to certain medications during an FDA-recognized drug shortage, when applicable legal requirements are met

In those circumstances, the FDA acknowledges that compounding can fill an important patient need. That ability to customize treatment is one of the reasons compounding continues to have a legitimate place in modern healthcare.

So Why Aren't Compounded Medications FDA Approved?

Because FDA approval is a specific premarket process designed for commercially manufactured drug products. Before an FDA-approved prescription drug can be marketed, its manufacturer generally has to submit data to the FDA supporting the product's safety, effectiveness, manufacturing quality, labeling, and other requirements. A compounded prescription does not go through that same product-by-product approval process.

Federal law provides specific pathways—primarily under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act—under which qualifying compounded drugs can receive exemptions from certain requirements that apply to conventionally manufactured drugs, including the FDA's new-drug premarket approval requirements. That is why compounded medications are accurately described as not FDA approved. It is a regulatory distinction. It does not mean that the practice of pharmacy compounding itself is unrecognized or prohibited.

What Does “Not FDA Approved” Actually Mean?

This is the part patients should understand clearly. When the FDA says a compounded medication is not FDA approved, it means the agency has not reviewed that specific compounded drug before marketing to verify its safety, effectiveness, or quality through the FDA drug-approval process.

That is different from saying:

“The FDA reviewed this medication and rejected it.”

That is generally not what the phrase means. The compounded product simply does not go through the same premarket approval pathway that a commercially manufactured brand-name or generic drug does. That is an important distinction.

Are Compounded Medications the Same as Generic Drugs?

No. This is another common misunderstanding. An FDA-approved generic medication must go through an FDA approval process and meet applicable requirements, including demonstrating equivalence to an approved brand-name drug. A compounded medication is different. The FDA specifically states that compounded drugs should not be described as generic versions of FDA-approved medications because generic drugs themselves are FDA approved while compounded products are not.

So even when a compounded prescription relates to a familiar medication, it should still be described accurately as a compounded medication, not an FDA-approved generic.

Why Use a Compounded Medication If FDA-Approved Drugs Exist?

For many patients, an FDA-approved medication will be the first and most appropriate choice. But healthcare is not always one-size-fits-all. There are situations in which the commercially available option simply does not meet a patient's medical needs.

A provider might need a different:

• Dosage
• Dosage form
• Combination
• Inactive-ingredient profile
• Route of administration
• Formulation

For example, imagine a patient needs an important medication but is allergic to a coloring ingredient used in the commercially available version. A compounding pharmacy may be able to prepare that prescription without the problem ingredient. Or perhaps a patient cannot swallow the only commercially available tablet.

A clinician may determine that a compounded liquid formulation is medically appropriate. These are exactly the types of patient-specific situations for which traditional pharmacy compounding developed. FDA recognizes that compounded drugs can serve an important role when an approved product cannot appropriately meet a patient's needs.

Compounding Is About Personalization—But There Are Rules

One of the most attractive things about compounding is flexibility. However, “customized” does not mean “anything goes.” Federal law places requirements and restrictions around how compounded medications can qualify under the 503A and 503B pathways.

For example, federal requirements address issues including:

• Who can perform compounding
• Patient-specific prescriptions
• Which bulk drug substances may be used
• Certain quality requirements
• Labeling
• Copies of commercially available or approved medications
• Drug shortages
• Distribution
• Adverse-event reporting in certain settings

The specific requirements depend partly on where and how the medication is compounded.

What Is a 503A Compounding Pharmacy?

When most patients imagine a traditional compounding pharmacy, they are generally thinking about the type of practice governed by Section 503A. Section 503A applies to qualifying compounding performed by a licensed pharmacist in a state-licensed pharmacy or federal facility, or by a licensed physician. In general, 503A compounding is tied to prescriptions for identified individual patients. These pharmacies are primarily overseen on a day-to-day basis by state boards of pharmacy, although the FDA can also perform certain inspections and enforcement activities. When all applicable 503A conditions are met, the compounded drugs qualify for exemptions from certain requirements that apply to conventional manufacturers, including FDA premarket approval and current good manufacturing practice requirements. That does not mean there are no standards. It means the regulatory framework is different from conventional pharmaceutical manufacturing.

What Is a 503B Outsourcing Facility?

A 503B outsourcing facility is another type of compounder established under federal law. These facilities can compound medications under a different framework and may prepare certain drugs without first receiving prescriptions for individually identified patients. Unlike qualifying 503A compounding, drugs produced by 503B outsourcing facilities are subject to current good manufacturing practice, or CGMP, requirements. 503B outsourcing facilities register with the FDA, are subject to FDA risk-based inspection, have product-reporting requirements, and must report certain adverse events.

The FDA maintains a public list of currently registered outsourcing facilities. One wording detail is important: A 503B facility can be FDA registered, but that does not mean the FDA has “approved” the pharmacy or approved each compounded medication it produces. The FDA specifically cautions companies against describing compounding pharmacies or outsourcing facilities as “FDA approved” or “FDA licensed.”

Are Compounded Medications Regulated?

Yes. They are simply regulated differently from FDA-approved manufactured medications. Traditional 503A pharmacies are generally overseen primarily by their state boards of pharmacy, with the FDA also having certain oversight and enforcement authority. 503B outsourcing facilities have more direct federal oversight and are subject to FDA registration, inspection, CGMP requirements, product reporting, and adverse-event reporting requirements.

So saying:

“Compounded medications aren't FDA approved.”

is accurate.

Saying:

“Compounded medications aren't regulated.”

would not be accurate.

What About the Ingredients Used in Compounded Medications?

This is another area where oversimplified statements can create confusion. It would not be accurate to say that every ingredient used in every compounded prescription is itself “FDA approved.” Instead, federal law establishes conditions around the bulk drug substances that qualifying compounders may use.

For example, under Section 503A, applicable bulk substances must meet certain statutory conditions involving recognized pharmacopeial standards, use in FDA-approved products, or inclusion on applicable FDA lists. Bulk substances are also subject to requirements involving certificates of analysis and manufacturing sources. This is one reason choosing where your prescription comes from matters.

Does “Not FDA Approved” Mean a Compounded Medication Doesn't Work?

The FDA-approval status alone does not tell you how a particular individual patient will respond to a compounded prescription. What it does tell you is that the specific compounded product has not undergone FDA's premarket review for safety, effectiveness, and quality. That distinction matters when talking about expectations.

Providers and telehealth companies should not advertise compounded medications as:

• FDA approved
• FDA-approved generics
• Identical to an FDA-approved product
• Clinically proven to produce the same result as an FDA-approved product when that claim has not been established

The FDA reiterated those advertising requirements in 2026. Patients deserve accurate information rather than exaggerated promises. That does not take away from the legitimate role of compounding. It simply means compounded medication should be discussed as compounded medication.

Are There Risks With Compounded Medications?

Yes. Just as prescription medications generally have risks, compounding has its own additional considerations. Because compounded products do not receive FDA premarket quality review, choosing a properly regulated and reputable compounding source is important. The FDA has documented cases in which poor compounding practices resulted in problems including:

• Contamination
• Too much active ingredient
• Too little active ingredient
• Quality problems
• Inadequate labeling
• Serious adverse events

Those risks are why regulatory standards, appropriate sourcing, provider oversight, correct dosing, and responsible pharmacy practices matter. A positive conversation about compounding should not require pretending those risks do not exist. In fact, understanding the differences is what allows patients to make better-informed decisions.

How Can Patients Be Smarter About Compounded Prescriptions?

If your provider recommends a compounded medication, asking a few questions can help you understand exactly what you are receiving.

Consider asking:

Why is a compounded medication being recommended?

Your provider should be able to explain why the compounded option makes sense for your particular medical situation.

Who is actually compounding the medication?

Know the pharmacy or outsourcing facility preparing your prescription.

The FDA specifically encourages patients purchasing compounded medications through telehealth or online services to understand the identity of the compounder rather than assuming the telehealth company itself manufactures the medication.

Is the pharmacy appropriately licensed or registered?

Traditional pharmacies are generally licensed through state pharmacy authorities.

503B outsourcing facilities can also be verified through the FDA's list of registered outsourcing facilities.

How should I take it?

Compounded formulations can use concentrations or dosing instructions that differ from commercially manufactured products.

Follow the instructions on your prescription, not instructions found online for someone else's medication.

Who do I contact if I have a problem?

You should know how to reach your provider or pharmacy if you have a side effect, dosing question, damaged shipment, or concern about your prescription.

Can Compounded Medications Be Made During Drug Shortages?

Under certain circumstances, yes. Federal compounding law contains provisions that can allow eligible compounders to prepare versions of medications appearing on the FDA's drug shortage list when applicable conditions are satisfied. This has been one of the important functions of compounding: helping address patient needs when an appropriate commercially manufactured medication is unavailable.

But shortage rules change as drug availability changes. A medication being eligible for certain compounding practices during a shortage does not necessarily mean the same rules continue after the shortage ends. That is why responsible providers and pharmacies have to stay current with FDA requirements.

Compounded Medications Aren't Supposed to Be a Back Door to Copy Every Drug

This is another important distinction. Federal law restricts qualifying compounders from routinely producing medications that are essentially copies of commercially available or FDA-approved drugs, although the exact rules differ between 503A pharmacies and 503B outsourcing facilities and can be affected by circumstances such as drug shortages. In other words, the purpose of compounding is not:

“Let's recreate every commercial medication without FDA approval.”

The traditional purpose is:

“This patient has a medical need that the available commercial product does not adequately meet.”

That distinction helps protect both patient access and the integrity of the FDA drug-approval system.

Why We Believe Transparency Matters

At Mr. Injection, we believe patients should understand what they are taking. If a medication is compounded, we should call it compounded. If a medication is not FDA approved, we should explain what that means. If there are differences between an FDA-approved medication and a compounded prescription, patients deserve to understand those differences before making a decision with their provider. You should never need confusing language or exaggerated claims to feel confident in your treatment plan. Compounding has a legitimate and valuable role in healthcare precisely because not every patient's needs fit neatly inside a commercially manufactured bottle or box.

But personalized medicine still requires responsible medicine.

That means:

• Appropriate medical evaluation
• A legitimate prescription
• A reputable compounding source
• Accurate dosing instructions
• Honest discussion of risks and benefits
• Ongoing provider oversight

The Bottom Line: “Not FDA Approved” Needs Context

When you hear that a compounded medication is “not FDA approved,” do not ignore the statement. But do not automatically misunderstand it either.

It means:

The compounded drug has not gone through FDA's product-specific premarket approval process for safety, effectiveness, and quality.

It does NOT mean that pharmacy compounding itself is an illegitimate practice.

Federal law specifically provides pathways for qualified compounding under Sections 503A and 503B, and the FDA recognizes that compounded medications can meet important medical needs when an FDA-approved medication cannot appropriately meet a patient's needs.

The better question is not simply:

“Is it FDA approved?”

It is:

“Why is this compounded medication being recommended for me, who is preparing it, and is it appropriate for my individual medical needs?”

That gives you a much more useful conversation to have with your provider.

Schedule a Free Consultation With Mr. Injection

Have questions about a medication you've been prescribed—or wondering whether a compounded treatment may be appropriate for your needs?

Schedule a free consultation with Mr. Injection to discuss your health goals, treatment options, and whether a compounded or commercially available medication may be appropriate for you.

Compounded medications are not FDA approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing. They are not appropriate for every patient or every situation. Treatment requires evaluation and a prescription from a qualified healthcare provider, and individual risks, benefits, and results vary.

Frequently Asked Questions About Compounded Medications

Why aren't compounded medications FDA approved?

Compounded medications are prepared under a different regulatory framework from conventionally manufactured drugs. When qualifying compounded products meet applicable requirements under Sections 503A or 503B of federal law, they are exempt from FDA's new-drug premarket approval requirements. This means the FDA does not review each compounded product for safety, effectiveness, and quality before it is marketed.

Are compounded medications legal?

Yes. Federal law specifically addresses human drug compounding under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. Compounders must meet applicable federal and state requirements depending on how and where the medication is prepared.

Are compounded medications regulated?

Yes, but differently from conventionally manufactured FDA-approved medications. State boards of pharmacy generally have primary responsibility for day-to-day oversight of traditional state-licensed compounding pharmacies, while FDA-registered 503B outsourcing facilities have additional federal requirements and FDA oversight.

What is the difference between a compounded medication and a generic medication?

FDA-approved generic drugs go through an FDA approval pathway and must meet applicable requirements, including demonstrating therapeutic equivalence to a reference drug. Compounded medications do not go through FDA premarket approval and should not be described as FDA-approved generics.

Why would a provider prescribe a compounded medication?

Compounding may be appropriate when an FDA-approved product cannot meet a patient's medical needs—for example, when a patient needs a different dosage form or cannot tolerate a particular ingredient in an available medication. Compounding may also be permitted under certain conditions when a medication appears on the FDA drug shortage list.

What is the difference between a 503A pharmacy and a 503B outsourcing facility?

503A generally applies to qualifying patient-specific compounding by licensed pharmacists in state-licensed pharmacies or federal facilities, or by licensed physicians. 503B applies to registered outsourcing facilities and includes requirements such as CGMP manufacturing standards, FDA registration, risk-based inspections, product reporting, and adverse-event reporting.

How do I know where my compounded medication comes from?

Ask your healthcare provider or dispensing service for the name of the pharmacy or outsourcing facility that prepared the medication. State pharmacy licensing can be verified through the applicable state authority, and the FDA maintains a public list of registered 503B outsourcing facilities.